Mark Borowsky
Overview
Explore the profile of Mark Borowsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rimel B, Enserro D, Bender D, Gunderson Jackson C, Tan A, Alluri N, et al.
Cancer
. 2023 Dec;
130(8):1234-1245.
PMID: 38127487
Purpose: This paper reports the efficacy of the poly (ADP-ribose) polymerase inhibitor olaparib alone and in combination with the antiangiogenesis agent cediranib compared with cediranib alone in patients with advanced...
2.
Palmieri A, Hicks V, Aikman N, Borowsky M, Haggerty A, ElSahwi K
South Med J
. 2023 Oct;
116(10):790-794.
PMID: 37788812
Objectives: Our objectives were to estimate the incidence of venous thromboembolism (VTE) after robotic staging for endometrial cancer and to compare the incidence of VTE in patients who received a...
3.
Curcio E, Miller B, Giglio A, Akoluk A, Erler B, Bosscher J, et al.
South Med J
. 2021 Nov;
114(11):680-685.
PMID: 34729610
Objective: Sentinel lymph node (SLN) sampling in endometrial cancer staging has become an acceptable standard. Indocyanine green dye injected into the cervix and detected by near-infrared light is technically simple...
4.
Vitobello A, Perner J, Beil J, Zhu J, Del Rio-Espinola A, Morawiec L, et al.
Life Sci Alliance
. 2019 Oct;
2(5).
PMID: 31615920
Liver cancer susceptibility varies amongst humans and between experimental animal models because of multiple genetic and epigenetic factors. The molecular characterization of such susceptibilities has the potential to enhance cancer...
5.
Dinkla K, Strobelt H, Genest B, Reiling S, Borowsky M, Pfister H
IEEE Trans Vis Comput Graph
. 2016 Nov;
23(1):591-600.
PMID: 27875174
High-throughput and high-content screening enables large scale, cost-effective experiments in which cell cultures are exposed to a wide spectrum of drugs. The resulting multivariate data sets have a large but...
6.
Cooney E, Borowsky M, Flynn C
Gynecol Oncol Rep
. 2016 Jan;
14:4-5.
PMID: 26793761
•Leiomyosarcoma in the vagina is rare.•Atypical fibroids recurring as leiomyosarcoma•Leiomyomas should be classified based on recurrence risk.
7.
Strobelt H, Alsallakh B, Botros J, Peterson B, Borowsky M, Pfister H, et al.
IEEE Trans Vis Comput Graph
. 2015 Nov;
22(1):399-408.
PMID: 26529712
Alternative splicing is a process by which the same DNA sequence is used to assemble different proteins, called protein isoforms. Alternative splicing works by selectively omitting some of the coding...
8.
Zhang X, Millet Y, Ausubel F, Borowsky M
Curr Protoc Mol Biol
. 2014 Oct;
108:7.18.1-7.18.16.
PMID: 25271717
Forward genetic analysis using ethyl methanesulfonate (EMS) mutagenesis has proven to be a powerful tool in biological research, but identification and cloning of causal mutations by conventional genetic mapping approaches...
9.
Bolles O, Borowsky M
Gynecol Oncol Case Rep
. 2013 Dec;
2(2):32-4.
PMID: 24371608
► Port-site metastases can occur following treatment for cervical cancer. ► Port-site metastases can occur following robotic assisted laparoscopic surgery. ► The pathogenesis of port-site metastases is poorly understood.
10.
Chen L, Stuart L, Ohsumi T, Burgess S, Varshney G, Dastur A, et al.
BMC Cancer
. 2013 Feb;
13:93.
PMID: 23442791
Background: The development of resistance to chemotherapies represents a significant barrier to successful cancer treatment. Resistance mechanisms are complex, can involve diverse and often unexpected cellular processes, and can vary...